Opposite effects of cholecystokinin octapeptide (CCK-8) and tetrapeptide (CCK-4) after injection into the caudal part of the nucleus accumbens or into its rostral part and the cerebral ventricles.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Neurochemistry International

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0197-0186(87)90074-XPMID 20501120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides

  2005cited by this paper
• Similar effect of caerulein on intracranial self-stimulation in vagotomized and non-vagotomized rats.

  1986cited by this paper
• Psychopharmacological Profile of Cholecystokinin Using the Self‐Stimulation and the Drug Discrimination Paradigms a

  1985cited by this paper
• Cholecystokinin Neuron Systems and Their Interactions with the Presynaptic Features of the Dopamine Neuron Systems

  1985cited by this paper
• Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence

  1985cited by this paper
• Specificity of nucleus accumbens to activities related to cholecystokinins in rats.

  1985cited by this paper
• Cholecystokinin tetrapeptide, proglumide and open-field behavior in rats.

  1984cited by this paper
• Effects of CCK-8 in the nucleus accumbens.

  1984cited by this paper
• Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.

  1984cited by this paper
• In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin.

  1984cited by this paper
• Long-lasting reduction of amphetamine-induced hyperactivity in rats after combined administration of caerulein with haloperidol.

  1984cited by this paper
• Effects of cholecystokinin on apomorphine-induced changes of motility in rats.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Differential effects of limbic versus striatal dopamine loss on motoric function.

  1983cited by this paper
• Minimized tolerance to the suppressive effects of CCK8 on operant responding.

  1983cited by this paper
• Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat.

  1983cited by this paper
• Modulation of [3H]-dopamine binding by cholecystokinin octapeptide (CCK-8).

  1982cited by this paper
• Cholecystokinin octapeptide: effects on the excitability of cultured spinal neurons.

  1982cited by this paper
• Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons.

  1981cited by this paper
• The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus.

  1981cited by this paper
• Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat.

  1980cited by this paper
• The actions of motilin, luteinizing hormone releasing hormone, cholecystokinin, somatostatin, vasoactive intestinal peptide, and other peptides on rat cerebral cortical neurons.

  1980cited by this paper
• Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection.

  1980cited by this paper
• Evidence for coexistence of dopamine and CCK in meso-limbic neurones

  1980cited by this paper
• A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing.

  1980cited by this paper
• Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

  1975cited by this paper
• New peptide in the vertebrate CNS reacting with antigastrin antibodies

  1975cited by this paper

• Prefrontal Cortical Circuit for Depression- and Anxiety-Related Behaviors Mediated by Cholecystokinin: Role of ΔFosB

  2014cites this paper
• Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro

  2004influential citation
• Central d-Ala2-Met5-enkephalinamide μ/δ-opioid receptor activation blocks behavioral sensitization to cholecystokinin in CD-1 mice

  2003cites this paper
• Central D-Ala2-Met5-enkephalinamide mu/delta-opioid receptor activation blocks behavioral sensitization to cholecystokinin in CD-1 mice.

  2003cites this paper
• Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.

  2003cites this paper
• The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors

  2000cites this paper
• CCK/dopamine interactions in Fawn-Hooded and Wistar-Kyoto rat brain.

  2000cites this paper
• Amphetamine-induced zif268 mRNA expression in the medial posterior nucleus accumbens in cholecystokinin-A receptor mutant rats.

  2000cites this paper
• No association between C-45T polymorphism in the Sp1 binding site of the promoter region of the cholecystokinin gene and alcoholism.

  1999cites this paper
• Relationship between SCL-90, Maudsley Personality Inventory and CCK4-induced intracellular calcium response in T cells.

  1998cites this paper
• Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry.

  1998cites this paper
• Cholecystokinergic innervation of nucleus accumbens subregions.

  1998cites this paper
• Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.

  1997cites this paper
• The effects of CCK-4 on dopamine D1 agonist-induced grooming are blocked by a CCK(A) receptor antagonist: evidence for a novel CCK receptor subtype?

  1997cites this paper
• Effects of microinjections of cholecystokinin and neurotensin into lateral hypothalamus and ventral mesencephalon on intracranial self-stimulation.

  1997cites this paper
• Interactions between Cholecystokinin and Other Neurotransmitter Systems

  1995cites this paper
• The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens

  1995cites this paper
• Cholecystokinin and Anxiety: From Neuron to Behavior

  1995cites this paper
• The stimulation of cholecystokinin receptors in the rostral nucleus accumbens significantly antagonizes the EEG and behavioural effects induced by phencyclidine in rats

  1995cites this paper
• CCK, Addiction and Anxiety

  1995cites this paper
• The CCK‐B Antagonist CI‐988 Increases Dopamine Levels in Microdialysate from the Rat Nucleus Accumbens via a Tetrodotoxin‐ and Calcium‐Independent Mechanism

  1995cites this paper
• Interaction of CCKB receptors with amphetamine in responding for conditioned rewards.

  1995cites this paper
• Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors.

  1994cites this paper
• Biological actions of cholecystokinin.

  1994cites this paper
• Rostral-caudal differences in effects of nucleus accumbens amphetamine on VTA ICSS.

  1994cites this paper
• Cholecystokinin Modulates Dopamine‐Mediated Behaviors

  1994cites this paper
• Cholecystokinin octapeptide (CCK-8) injected into a cerebral ventricle induces a fever-like thermoregulatory response mediated by type B CCK-receptors in the rat.

  1994cites this paper
• Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens.

  1993cites this paper
• Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats.

  1993cites this paper
• Opposite effects of mesencephalic microinjections of cholecystokinin octapeptide and neurotensin-(1-13) on brain stimulation reward.

  1993cites this paper
• The selective CCK-B agonist, BC 264 injected in the antero-lateral part of the nucleus accumbens, reduces the spontaneous alternation behaviour of rats.

  1992cites this paper
• Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment.

  1992cites this paper
• Balance of glutamate and dopamine in the nucleus accumbens modulates self-stimulation behavior after injection of cholecystokinin and neurotensin in the rat brain.

  1992cites this paper
• Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.

  1992cites this paper
• Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway

  1992cites this paper
• Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour?

  1991cites this paper
• Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264

  1990cites this paper
• Coexistence of Neuropeptides and “Classical” Neurotransmitters

  1990cites this paper
• Behavioral characterization of intracranial self-stimulation from mesolimbic, mesocortical, nigrostriatal, hypothalamic and extra-hypothalamic sites in the non-inbred CD-1 mouse strain.

  1990cites this paper
• Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration.

  1989cites this paper
• Synthesis of tritium labelled CCK4 (Trp‐Met‐Asp‐[3H]Phe‐NH2)

  1989cites this paper
• Similar potencies of CCK-8 and its analogue BOC(Nle28;Nle31)CCK27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogue.

  1989cites this paper
• CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens.

  1989cites this paper
• Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward.

  1989cites this paper
• Modulation of Mesolimbic Dopaminergic Behaviors by Cholecystokinin

  1988cites this paper
• Postnatal development of cholecystokinin (CCK) binding sites in the rat forebrain and midbrain: an autoradiographic study.

  1988cites this paper
• Kelatorphan, a potent enkephalinases inhibitor, presents opposite properties when injected intracerebroventricularly or into the nucleus accumbens on intracranial self-stimulation.

  1988cites this paper
• Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens.

  1988cites this paper
• Neuroleptic-like properties of cholecystokinin analogs: distinctive mechanisms underlying similar behavioral profiles depending on the route of administration.

  1988cites this paper
• Characterization of [3H] CCK4 binding sites in mouse and rat brain.

  1988cites this paper